Evidence map›Paper›PMID 26432745›Full record

ArticleIndian heart journal

Missing diagnosis: gingival hypertrophy due to amlodipine.

L R Tomar, A Aggarwal

Abstract readCase Reports
In one paragraph

Article in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

L R TomarSenior Resident, Department of Medicine, University College of Medical Sciences & Guru Teg Bahadur Hospital (University of Delhi), Delhi110095, India. Electronic address: drlaxmikantucms@gmail.com.
A AggarwalAssistant Professor, Department of Medicine, University College of Medical Sciences & Guru Teg Bahadur Hospital (University of Delhi), Delhi110095, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gingival hypertrophy (GH) is a well-known physical manifestation due to inflammatory conditions, pregnancy, vitamin C deficiency, systemic diseases like leukemia, Wegners granulomatosis, and various drugs like anticonvulsants, immunosuppresant, and calcium channel blockers (CCBs).We present here a case of a 45-year-old woman, who has been taking Amlodipine 10mg once a day together with Atenelol 50mg per day for one and half years, and has subsequently developed gum hypertrophy. This manifestation was reversed after stopping of Amlodipine. Though this case presentation is described in literature, we hereby present it in a pictorial form, to sensitize the treating physician toward it.

Indexed as

Diagnostic ErrorsAmlodipineCalcium Channel BlockersFemaleGingivaGingival HypertrophyHumansHypertensionMiddle AgedAmlodipineCalcium Channel BlockersAmlodipineCalcium channel blockerGingival hypertrophy

Identifiers

PMID26432745
PMCPMC4593806

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.